Funded Health Care Startups in Munich
Eleven Health Care startups in Munich show a wide spread in disclosed round sizes, with Avelios Medical’s $31M Series A (2025-02-06) and Smart Reporting’s…
Eleven Health Care startups in Munich show a wide spread in disclosed round sizes, with Avelios Medical’s $31M Series A (2025-02-06) and Smart Reporting’s $25M Series C (2024-04-22) sitting far above the mid-teens of the rest, while most disclosed rounds cluster much lower. A clear outlier in timing appears in 2025: two of the 11 rows have round dates in 2025 (AlfaDocs is 2025-05-14 but undisclosed; Caire is $890K on 2025-02-21), whereas the next latest disclosed entries resume in 2024 and earlier.
The stage mix is concentrated in venture funding labels rather than early checks alone, but two very small disclosed anchors remain: Kranus Health’s $1M Seed on 2021-02-04 and CereGate’s $100K Series A on 2022-01-12. Geographically, every row is listed in Munich, Bayern, Germany, so the “Munich” constraint is consistent across names and dates. Disclosures are mostly provided: 10 of 11 rows list an amount, with one undisclosed round (AlfaDocs, 2025-05-14).
Most recent rounds
11 shownRelated listings
Frequently asked
What’s the largest disclosed round in these Munich health care deals, and how far ahead is it of the next-largest?
The largest disclosed amount is Avi Medical’s $55M Series B (2022-04-06). That $55M dwarfs the next-largest disclosed rounds in the table: Smart Reporting at $25M (2024-04-22) and Avelios Medical at $31M (2025-02-06), with other disclosed amounts like EGYM’s $41M (2021-09-16) still below the $55M peak.
Are there any clusters in round timing within the most recent period shown?
Yes. Within the table’s 2024–2025 window, there are four entries: Smart Reporting ($25M, 2024-04-22), Avi Medical ($55M, 2022 is outside), plus Caire ($890K, 2025-02-21) and AlfaDocs (undisclosed, 2025-05-14), and Avelios Medical ($31M, 2025-02-06). The most recent date is 2025-05-14 (AlfaDocs), while the oldest dated row is 2021-02-04 (Kranus Health, Seed $1M).
Which stage labels dominate, and how does the mix look across early vs later rounds?
Across the 11 rows, the most common explicit stage labels are Series A and Seed (each appears twice): Series A includes Avelios Medical $31M (2025-02-06) and Kranus Health $9M (2023-10-02), while Seed includes Vantis $5M (2021-04-01) and Kranus Health $1M (2021-02-04). Later-stage labels are present as well, including Series E for EGYM $41M (2021-09-16) and Series C for Smart Reporting $25M (2024-04-22).
How concentrated is the geography here, and are there any city patterns to flag?
All 11 entries are listed in Munich, Bayern, Germany, so there is no intra-list city variation (including no alternate districts/cities within the table). The only pattern to flag is name repetition for Kranus Health with two different Munich rounds: $1M Seed (2021-02-04) and $9M Series A (2023-10-02).
Are there disclosure outliers or amount outliers that stand out for diligence?
Yes on both fronts. On disclosure, AlfaDocs (2025-05-14) is the only undisclosed amount, while the other 10 rows provide amounts (e.g., CereGate at $100K Series A on 2022-01-12). On amount extremes, CereGate’s $100K and Kranus Health’s $1M Seed (2021-02-04) sit at the low end compared with the $55M Avi Medical Series B (2022-04-06).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.